Naloxone or vagotomy does not influence centrally octreotide-induced inhibition of gastric acid secretion in rats

Abstract

To investigate the effect of preceding naloxone injection into the third cerebroventricle or acute subdiaphragmatic vagotomy on the gastric acid secretion inhibited by the somatostatin analogue octreotide given by intracerebroventricular (icv) injection. The third ventricles were cannulated in male Wistar rats anesthetized with sodium pentobarbital. One week later, acute gastric lumen perfusion was carried out. The gastric perfusion samples were collected every 10 min and were titrated by 0.01 mol/L NaOH to neuter. On the basis of subcutaneous injection of pentagastrin (G-5, 160 μ g/kg), icv injection of physiological saline (group A, n=20), icv injection of octreotide (0.05 μ g) (group B, n=20), icv injection of naloxone (2.5 μ g)+octreotide (0.05 μ g) (group C, n=20), acute subdiaphragmatic vagotomy+ icv injection of physiological saline (group D, n=20), or acute subdiaphragmatic vagotomy+icv injection of octreotide (0.05 μ g) (group E, n=20) were conducted. Before and after icv injection, 1-h total acid output (TAO) was determined and compared. The experimental data were expressed in change rate (%) of TAO. The change rates (%) of TAO were 4.60% in group A, −20.35% in group B, −18.06% in group C, 5.01% in group D and −21.59% in group E, respectively. Comparison of group B or C versus group A showed that P<0.01 and comparison between the group E versus group D showed that P<0.01. Whereas the differences between group C and group B, group E and group B were not statistically significant (P>0.05 for all). The results indicate that the central inhibition of gastric acid secretion by octreotide may not be mediated by the endogenous opiate substance or its receptor and the peripheral pathway for icv injection of octreotide to suppress gastric acid secretion is via extra-vagus route.

Keywords

octreotide / somatostatin analogue / intracerebroventricular injection / gastric acid / naloxone

References

[1] PawlikoswskiM., Melen-MuchaG.. Somatostatin analogs—from new molecules to new applications. Curr Opin Pharmacol, 2004, 4(6): 608-613

[2] GaoF., LuG. Q.. Effect of injection of SMS201–995 into third ventricle on the gastrin-induced gastric acid secretion in rats. Acta Univ Med Tongji, 1998, 27(Suppl2): 168-170

[3] WangZ. L., LuG. Q.. Effect of intraventricular administration of histamine and its receptor agonists on pentagastrin-induced gastric acid secretion. Acta Physiol Sin, 1992, 44(3): 261-268

[4] YonedaM., TacheY.. SMS 201–995-induced stimulation of gastric acid secretion via the dorsal vagal complex and inhibition via the hypothalamus in anaesthetized rats. Br J Pharmacol, 1995, 116(4): 2303-2309

[5] YonedaM., RaybouldH., TacheY.. Central action of somatostatin analog, SMS 201–995, to stimulate gastric acid secretion in rats. Peptides, 1991, 12(3): 401-406

[6] ShiraishiT.. Hypothalamic control of gastric acid secretion. Brain Res Bull, 1988, 20(6): 791-797

[7] MartinezV., CoyD. H., LioydK. C., et al.. Intracerebroventricular injection of somatostatin sst5 receptor agonist inhibits gastric acid secretion in rats. Eur J Pharmacol, 1996, 296(2): 153-160

[8] TacheY., GotoY., GunionM., et al.. Inhibition of gastric acid secretion in rats and in dogs by corticotropin-releasing factor. Gastroenterology, 1984, 86(2): 281-286

[9] SrikantC. B., PatelY. C.. Cysteamine-induced depletion of brain somatostatin is associated with up-regulation of cerebrocortical somatostatin receptors. Endocrinology, 1984, 115(3): 990-995

[10] ReichlinS.. Somatostatin. N Engl J Med, 1983, 309(25): 1556-1563

[11] ChaikofL., JankeW. H., PesarosP. C., et al.. Effects of prednisone and corticotropin on gastric secretion. Experiments in Heidenhain pouch dogs. Arch Surg, 1991, 83: 32-41

[12] BrownM. R., RevierC., ValeW.. Central nervous system regulation of adrenocorticotropin secretion: role of somatostatins. Endocrinology, 1984, 5: 1546-1549

[13] MorleyJ. E., LevineA. S., SilvisS. E.. Central regulation of gastric acid secretion: the role of neuropeptides. Life Sci, 1982, 5: 399-410

[14] SomogyiP., HodgsonA. J., SmithA. D., et al.. Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin-or cholecystokinin-immunoreactive material. J Neurosci, 1984, 10: 2590-2603

[15] GothertM.. Somatostatin selectively inhibits noradrenaline release from hypothalamic neurones. Nature, 1980, 5786: 86-88

[16] YuZ. W., WuR.. The second stimulatory pathway of gastric acid secretion—sympathetic nervous system. Prog Physiol Sci, 1984, 4: 325-328

[17] ChibaT., YamadaT.. WalshJ.H., DockrayG.J.. Gut somatostatin. Gut peptides, 1994, New York, Raven Press Ltd: 123-145